A new law in New Jersey is regulating the manufacturing and sale of Delta-8 products, a cannabis derivative that has become increasingly popular in recent years. The law aims to address concerns regarding the product’s potency and potential health risks.
Delta-8 is a psychoactive compound found in cannabis that is similar to THC, the main psychoactive component in marijuana. However, Delta-8 is derived from hemp, which contains lower levels of THC. This has made it a popular alternative for those looking to experience the effects of THC without the intense high.
The new law in New Jersey requires manufacturers to obtain a permit to produce Delta-8 products and ensures that these products are properly labeled with their exact cannabinoid content. This is important as some Delta-8 products have been found to contain higher levels of THC than advertised, putting consumers at risk of experiencing unexpected and potentially harmful effects.
Additionally, the law prohibits the sale of Delta-8 products to individuals under the age of 21, similar to regulations surrounding the sale of alcohol and tobacco products. This measure is intended to protect young people from the potential risks associated with using Delta-8.
Overall, the new law aims to provide consumers with a safe and regulated market for Delta-8 products, ensuring that they are accurately labeled and do not pose any unexpected health risks. By implementing these regulations, New Jersey is taking steps to address the growing popularity of Delta-8 while prioritizing consumer safety and public health.
Source
Photo credit news.google.com